Mutational analysis of the PRL receptor gene in human breast tumors with differential PRL receptor protein expression.
暂无分享,去创建一个
P. Kelly | S. Bornstein | L. Horn | A. Glasow | J. Gillespie | B. Vonderhaar | C. Stratakis | S. Taymans | U. Kohler
[1] C. Clevenger,et al. Functional Characterization of the Intermediate Isoform of the Human Prolactin Receptor* , 1999, The Journal of Biological Chemistry.
[2] P. Ingleton,et al. Dissociation of Janus Kinase 2 and Signal Transducer and Activator of Transcription 5 Activation after Treatment of Nb2 Cells with a Molecular Mimic of Phosphorylated Prolactin1. , 1999, Endocrinology.
[3] Kirschner Ls,et al. Large-scale preparation of sequence-ready bacterial artificial chromosome DNA using QIAGEN columns. , 1999 .
[4] P. Kelly,et al. Should prolactin be reconsidered as a therapeutic target in human breast cancer? , 1999, Molecular and Cellular Endocrinology.
[5] Y. Bignon,et al. Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines. , 1999, Biochemical and biophysical research communications.
[6] S. Anderson,et al. Constitutive Activation of the Prolactin Receptor Results in the Induction of Growth Factor-independent Proliferation and Constitutive Activation of Signaling Molecules* , 1999, The Journal of Biological Chemistry.
[7] J. Manson,et al. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. , 1999, Journal of the National Cancer Institute.
[8] S. Amselem,et al. Defects of the growth hormonereceptor and their clinical implications , 1999 .
[9] J. Meng,et al. The human prolactin receptor gene structure and alternative promoter utilization: the generic promoter hPIII and a novel human promoter hP(N). , 1999, The Journal of clinical endocrinology and metabolism.
[10] B. Teh,et al. The genetic basis of breast cancer and its clinical implications. , 1999, The Australian and New Zealand journal of surgery.
[11] Hindle Wh. Hormone alterations in breast cancer: examining the hypotheses. , 1999 .
[12] S. Amselem,et al. Defects of the growth hormone receptor and their clinical implications. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[13] W. Hindle. Hormone alterations in breast cancer: examining the hypotheses. , 1999, Medscape women's health.
[14] C. Stratakis,et al. Large-scale preparation of sequence-ready bacterial artificial chromosome DNA using QIAGEN columns. , 1999, BioTechniques.
[15] P. Ingleton,et al. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin. , 1999, Endocrinology.
[16] W. Scherbaum,et al. Expression of Ob receptor in normal human adrenals: differential regulation of adrenocortical and adrenomedullary function by leptin. , 1998, The Journal of clinical endocrinology and metabolism.
[17] K. Horwitz,et al. Convergence of Progesterone with Growth Factor and Cytokine Signaling in Breast Cancer , 1998, The Journal of Biological Chemistry.
[18] T. Fujikawa,et al. Cooperative and differential effects of estrogen, prolactin, 22K and 20K human growth hormones on cyclin D1/PRAD1 gene expression in T‐47D human breast cancer cells , 1998, Biochemistry and molecular biology international.
[19] C. Brooks,et al. Phosphorylation of bovine prolactin eliminates luteotropic activity in the rat. , 1998, Life sciences.
[20] B. Vonderhaar. Prolactin: the forgotten hormone of human breast cancer. , 1998, Pharmacology & therapeutics.
[21] P. Kelly,et al. Differential expression of prolactin receptor (PRLR) in normal and tumorous adrenal tissues: separation of cellular endocrine compartments by laser capture microdissection (LCM). , 1998, Endocrine research.
[22] P. Kelly,et al. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. , 1998, Endocrine reviews.
[23] M. Waters,et al. Cellular expression of growth hormone and prolactin receptors in human breast disorders , 1998, International journal of cancer.
[24] P. Kelly,et al. Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. , 1998, The Journal of clinical endocrinology and metabolism.
[25] C. Ohlsson,et al. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. , 1997, The Journal of clinical investigation.
[26] C. Powell,et al. Printed in U.S.A. Copyright © 1997 by The Endocrine Society Expression of Prolactin and Its Receptor in Human Breast Carcinoma* , 2022 .
[27] Robert F. Bonner,et al. Laser Capture Microdissection: Molecular Analysis of Tissue , 1997, Science.
[28] R. Blamey,et al. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. , 1997, The Journal of clinical endocrinology and metabolism.
[29] P. Kelly,et al. Internalization of prolactin receptor and prolactin in transfected cells does not involve nuclear translocation. , 1997, Journal of cell science.
[30] R. D'Andrea,et al. Activating mutations in cytokine receptors: implications for receptor function and role in disease. , 1997, Blood.
[31] P. Wingo,et al. Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.
[32] P. Chikhlikar,et al. Node negative breast carcinoma: Hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators , 1996, Journal of surgical oncology.
[33] J. Rommens,et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds , 1996, Nature Genetics.
[34] R. Gelber,et al. IX. International consensus conference on primary treatment of breast cancer. , 1996, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[35] C. Watson,et al. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. , 1995, British Journal of Cancer.
[36] J. Leonardelli,et al. [Immunocytochemical analysis of human prolactin receptors using anti-idiotypic antibodies in human breast cancer]. , 1995, Annales de pathologie.
[37] S. Seal,et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.
[38] B. Vonderhaar,et al. Characterization of a monoclonal antibody against human prolactin receptors , 1993, International journal of cancer.
[39] T. Hoffmann,et al. Glycosylation of human prolactin regulates hormone bioactivity and metabolic clearance , 1993, Journal of endocrinological investigation.
[40] H. LaVoie,et al. Glucocorticoid-Prolactin Interactions in Nb2 Lymphoma Cells: Antiproliferative versus Anticytolytic Effects , 1993, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[41] R. Sutherland,et al. Mechanisms of prolactin receptor regulation in mammary gland , 1993, Molecular and Cellular Endocrinology.
[42] Phillips Rd. Molecular biology of growth hormone receptor dysfunction. , 1992 .
[43] B L De Stavola,et al. Relationship of blood prolactin levels and the risk of subsequent breast cancer. , 1992, International journal of epidemiology.
[44] J. Phillips. Molecular biology of growth hormone receptor dysfunction. , 1992, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[45] J. Bonneterre,et al. Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer , 1990, The Journal of Steroid Biochemistry and Molecular Biology.
[46] D. Ingram,et al. Prolactin and breast cancer risk , 1990, The Medical journal of Australia.
[47] S. de Placido,et al. Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study. , 1990, British Journal of Cancer.
[48] R. Callahan,et al. Mutations in human breast cancer: an overview. , 1989, Journal of the National Cancer Institute.
[49] S. Tandon,et al. Highly specific sites of prolactin binding in benign and malignant breast tissue. , 1989, Indian journal of experimental biology.
[50] P. Kelly,et al. Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. , 1989, Molecular endocrinology.
[51] L. J. Lewis,et al. Two forms of glycosylated human prolactin have different pigeon crop sac-stimulating activities. , 1989, Endocrinology.
[52] W. Lotze. [The epidemiology and etiology of breast cancer]. , 1989, Zentralblatt fur Gynakologie.
[53] M. Eigenbrodt,et al. Anti-growth action on mouse mammary and prostate glands of a monoclonal antibody to prolactin receptor. , 1988, The American journal of pathology.
[54] A. Schally,et al. Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer. , 1988, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[55] B. Mobbs,et al. Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer. , 1987, Journal of steroid biochemistry.
[56] H. Vorherr. Endocrinology of breast cancer. , 1987, Maturitas.
[57] W. Remmele,et al. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. , 1987, Der Pathologe.
[58] H. Imura,et al. Prognostic value of estrogen and prolactin receptor analysis in human breast cancer. , 1985, Japanese journal of cancer research : Gann.
[59] H. Rauschecker,et al. Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer , 1984, International journal of cancer.
[60] P. Kao,et al. Demonstration of biological activity of prolactin molecular weight variants in human sera. , 1984, The Journal of clinical endocrinology and metabolism.
[61] L. Murphy,et al. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. , 1984, Cancer research.
[62] R. Walker,et al. The localization of prolactin binding sites in human breast tissue , 1983, International journal of cancer.
[63] J. Bonneterre,et al. Prolactin receptors in human breast cancer. , 1982, European journal of cancer & clinical oncology.
[64] R. Hähnel,et al. Prolactin receptors in human breast carcinoma , 1979, Cancer.
[65] H. Friesen,et al. Hormone binding by human mammary carcinoma. , 1977, Cancer research.
[66] H. Nagasawa,et al. Prolactin and murine mammary tumorigenesis: a review. , 1977, Cancer research.